Kalocsay, Marian http://orcid.org/0000-0002-4187-5829
Berberich, Matthew J.
Everley, Robert A. http://orcid.org/0000-0003-0460-5229
Nariya, Maulik K.
Chung, Mirra
Gaudio, Benjamin http://orcid.org/0000-0002-7003-5052
Victor, Chiara
Bradshaw, Gary A. http://orcid.org/0000-0001-9724-6100
Eisert, Robyn J.
Hafner, Marc http://orcid.org/0000-0003-1337-7598
Sorger, Peter K. http://orcid.org/0000-0002-3364-1838
Mills, Caitlin E. http://orcid.org/0000-0002-2608-4084
Subramanian, Kartik http://orcid.org/0000-0002-6900-8882
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Strategic Coordination (U54 HL127365, U54 HL127365, U54 HL127365, U54 HL127365, U54 HL127365, U54 HL127365, U54 HL127365, U54 HL127365, U54 HL127365, U54 HL127365, U54 HL127365, U54 HL127365)
U.S. Department of Health & Human Services | NIH | Office of Strategic Coordination
U.S. Department of Health & Human Services | NIH | Office of Strategic Coordination
U.S. Department of Health & Human Services | NIH | Office of Strategic Coordination
U.S. Department of Health & Human Services | NIH | Office of Strategic Coordination
U.S. Department of Health & Human Services | NIH | Office of Strategic Coordination
U.S. Department of Health & Human Services | NIH | Office of Strategic Coordination
U.S. Department of Health & Human Services | NIH | Office of Strategic Coordination
U.S. Department of Health & Human Services | NIH | Office of Strategic Coordination
U.S. Department of Health & Human Services | NIH | Office of Strategic Coordination
U.S. Department of Health & Human Services | NIH | Office of Strategic Coordination
U.S. Department of Health & Human Services | NIH | Office of Strategic Coordination
Article History
Received: 11 January 2021
Accepted: 3 July 2023
First Online: 4 August 2023
Competing interests
: PKS is a co-founder and member of the BOD of Glencoe Software, a member of the BOD for Applied Biomath, and a member of the SAB for RareCyte, NanoString and Montai Health; he holds equity in Glencoe, Applied Biomath and RareCyte. PKS is a consultant for Merck and the Sorger lab has received research funding from Novartis and Merck in the past five years. Sorger declares that none of these relationships have influenced the content of this manuscript. KS is currently an employee of Bristol Myers Squibb, MH is an employee of Genentech, and RAE and MJB are employees of Frontier Medicines. The other authors declare no outside interests.